首页> 外国专利> isolated mammalian antibody or antigen-binding fragment thereof, caninized antibody or caninized antigen binding fragment thereof, caninized monoclonal antibody or antigen-binding fragment thereof, isolated nucleic acid, expression vector, host cell, peptide isolated, fusion protein, pharmaceutical composition, and method for decreasing the activity of an immune cell?

isolated mammalian antibody or antigen-binding fragment thereof, caninized antibody or caninized antigen binding fragment thereof, caninized monoclonal antibody or antigen-binding fragment thereof, isolated nucleic acid, expression vector, host cell, peptide isolated, fusion protein, pharmaceutical composition, and method for decreasing the activity of an immune cell?

机译:分离的哺乳动物抗体或其抗原结合片段,犬化抗体或其抗原结合片段,犬化单克隆抗体或其抗原结合片段,分离的核酸,表达载体,宿主细胞,分离的肽,融合蛋白,药物组合物和方法降低免疫细胞的活性?

摘要

The present invention describes canine IL-4 alpha receptor blocking antibodies and antibodies that have specific sequences and a high binding affinity for the canine IL-4 α receptor. The present invention also describes the use of the antibodies of the present invention in the treatment of atopic dermatitis in dogs. The present invention further describes specific epitopes that bind to canine il-4 alpha receptor antibodies.
机译:本发明描述了犬IL-4α受体阻断抗体和对犬IL-4α受体具有特异性序列和高结合亲和力的抗体。本发明还描述了本发明的抗体在治疗犬特应性皮炎中的用途。本发明进一步描述了结合犬il-4α受体抗体的特异性表位。

著录项

  • 公开/公告号BR112017020915A2

    专利类型

  • 公开/公告日2018-07-10

    原文格式PDF

  • 申请/专利权人 INTERVET INTERNATIONAL B.V.;

    申请/专利号BR20171120915

  • 发明设计人 MOHAMAD MORSEY;YUANZHENG ZHANG;

    申请日2016-04-01

  • 分类号A61K39/395;A61P37;C07K14/715;C07K16/28;C12N15/13;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号